Associated Researcher at Lanzhou University Second Hospital, China
Dr. Huili Ye is an emerging researcher in the fields of tumor immunotherapy, epigenetics, and the tumor microenvironment, with a strong focus on gastric cancer. She is currently pursuing her Ph.D. in General Surgery at Lanzhou University while serving as an Assistant Researcher and Master’s supervisor at The Second Hospital of Lanzhou University. Dr. Ye has led and contributed to multiple nationally funded and provincial projects, including studies on CAR-T cell therapy, lipid metabolism reprogramming, and novel immunotherapeutic strategies. Her research output is distinguished by high-impact publications in renowned journals such as Cancer Research, Nature Communications, Science Advances, and Gastroenterology, reflecting both depth and international collaboration. Beyond her scientific work, she is actively engaged in academic mentorship, interdisciplinary initiatives, and fostering innovative approaches in translational oncology. With her blend of academic rigor, leadership capacity, and collaborative vision, Dr. Ye represents a promising force in advancing future cancer research.
Professional Profile
Scopus Profile
Education
Dr. Huili Ye has pursued an impressive academic journey across some of China’s leading institutions. She began her scientific training at the School of Life Sciences, Northwest Normal University, earning a Bachelor’s degree, where she built a strong foundation in biological sciences. To deepen her expertise, she joined Zhejiang University, completing a Master’s degree in Cell Biology, focusing on molecular and cellular processes with translational potential. Driven by her passion for advancing cancer research, Dr. Ye is currently completing her Doctoral studies in General Surgery at Lanzhou University’s Second Clinical Medical College. Her doctoral research integrates clinical perspectives with molecular biology, emphasizing tumor biology and innovative treatment strategies. Through this trajectory, she has built a rare combination of laboratory research skills and clinical insight, equipping her to contribute to the frontiers of tumor immunology, cancer epigenetics, and translational medicine with both depth and precision.
Experience
Dr. Ye has gained extensive academic and professional experience that bridges laboratory science with clinical application. she has served as an Assistant Researcher and Master’s Supervisor at The Second Hospital of Lanzhou University, actively guiding graduate students while leading her independent research initiatives. She has secured competitive funding as Principal Investigator on projects supported by the National Natural Science Foundation of China and institutional innovation programs. Additionally, she has played key roles in large-scale provincial projects, such as the development of targeted immunotherapies for gastrointestinal tumors, strengthening her expertise in collaborative, multidisciplinary research. Dr. Ye has worked with international scholars from Europe and Japan, enhancing the global relevance of her studies. Her publication record in highly ranked journals highlights her ability to carry research from concept to impactful discovery. This experience reflects a dynamic blend of scientific innovation, clinical translation, mentorship, and international collaboration.
Research Interest
Dr. Ye’s research interests lie at the forefront of cancer biology and translational medicine, with a particular emphasis on tumor immunotherapy, tumor epigenetics, and the tumor microenvironment. Her work explores how molecular mechanisms drive immune escape, treatment resistance, and tumor progression, aiming to identify new therapeutic targets. She has made significant contributions to the study of PICH-mediated mechanisms in gastric cancer, uncovering pathways linked to lipid metabolism, S-phase transition, and chemoresistance. Furthermore, Dr. Ye is advancing innovative CAR-T cell therapies and nanobody-based delivery systems, positioning her research at the intersection of immunology and precision oncology. By integrating basic molecular biology with clinical applications, her projects are designed to accelerate the development of targeted interventions that improve treatment outcomes for gastrointestinal malignancies. Her ongoing investigations highlight not only her scientific creativity but also her determination to contribute meaningful solutions to one of medicine’s most pressing global challenges.
Awards and Honors
Dr. Ye’s academic journey has been marked by prestigious research grants, impactful publications, and recognition from the scientific community. She has successfully secured funding from the National Natural Science Foundation of China, underscoring the novelty and importance of her independent research. Her leadership in institutional and provincial innovation projects highlights her standing as a promising investigator in oncology. Several of her peer-reviewed papers have been published in top-tier international journals, including Cancer Research, Science Advances, Nature Communications, and Gastroenterology, reflecting both the quality and global relevance of her work. Beyond research, her role as a Master’s degree supervisor represents recognition of her academic mentorship and leadership potential. These achievements showcase her ability to drive high-impact discoveries, foster interdisciplinary collaborations, and train future researchers. Together, they affirm her status as an emerging leader in cancer research and position her strongly for competitive international honors and awards.
Publication Top Notes
Conclusion
Dr. Huili Ye embodies the qualities of a dedicated and innovative researcher whose work significantly advances the fields of cancer biology and immunotherapy. Her journey reflects a rare combination of strong academic foundation, international collaborations, and translational research achievements. By successfully leading funded projects and publishing in highly reputed journals, she demonstrates both scientific rigor and visionary impact. As an educator and mentor, she is nurturing the next generation of biomedical scientists while contributing to the academic community at large. Her exploration of novel therapies, such as CAR-T approaches for gastric cancer, showcases her ability to merge cutting-edge science with clinical application. Looking ahead, Dr. Ye is well positioned to expand her influence through global collaborations, keynote contributions, and editorial involvement, further amplifying her leadership. These accomplishments and her clear trajectory of growth make her highly deserving of recognition as a Best Researcher Award recipient.